Alert Header goes here

Rutland Regional Medical Center

Be sure the class of "ShowPanel" is added to the div of "AlertPanel" or the panel will not show.

An image can be added. Be sure to add the class of "Left" or "Right" if the text should flow around it.

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Itaque hic eos quasi nisi adipisci voluptas maxime placeat atque fugiat doloremque sint modi necessitatibus ea impedit laborum, distinctio, totam, quo nihil.

Skip to Content

A Randomized Phase III Trial of Lenalidomide vs. Observation Alone in High-Risk Myeloma

Objective
ECOG E3A06 A Randomized Phase III Trial of Lenalidomide vs. Observation Alone in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma

Myeloma: The purpose of this study is to find out what effects (good and bad) the use of the drug lenalidomide has on patients and their multiple myeloma, and to compare this with patients that receive no therapy.

Contact
Rebecca Denofer, RN, OCN at 802-747-1692
or rdenofer@rrmc.org

RUTLAND REGIONAL MEDICAL CENTER160 Allen Street, Rutland, VT 05701802.775.7111

© 2019 Rutland Medical Center